Table 3 Prevalence (and rank order) of diagnosis groups by gender and age group
Diagnosis group | total (n = 3,189) | female (n = 1,891) | male (n = 1,298) | age 65-74 (n = 1,827) | age 75-84 (n = 1,362) |
|---|---|---|---|---|---|
Hypertension | 77.9% (1) | 77.5% (1) | 78.4% (1) | 74.5% (1) | 82.4% (1) |
Lipid metabolism disorders | 58.5% (2) | 57.0% (2) | 60.8% (2) | 60.5% (2) | 56.0% (2) |
Chronic low back pain | 49.5% (3) | 55.2% (3) | 41.1% (5) | 48.3% (3) | 51.0% (3) |
Joint arthrosis§ | 43.3% (4) | 48.9% (4) | 35.3% (6) | 39.4% (4) | 48.7% (4) |
Diabetes mellitus§ | 37.6% (5) | 33.3% (6) | 43.8% (4) | 38.8% (5) | 36.0% (6) |
Thyroid dysfunction§ | 33.8% (6) | 43.5% (5) | 19.6% (13) | 35.8% (6) | 31.1% (7) |
Chronic ischemic heart disease§ | 31.4% (7) | 22.2% (12) | 44.7% (3) | 27.8% (7) | 36.1% (5) |
Cardiac arrhythmias§ | 26.9% (8) | 23.5% (9) | 31.9% (7) | 24.0% (9) | 30.8% (8) |
Asthma/Chronic obstructive pulmonary disease§ | 24.2% (9) | 23.1% (10) | 25.7% (9) | 24.2% (8) | 24.2% (10) |
Lower limb varicosis§ | 23.3% (10) | 28.8% (8) | 15.2% (17) | 21.7% (10) | 25.3% (9) |
Osteoporosis§ | 19.8% (11) | 28.9% (7) | 6.6% (27) | 17.5% (13) | 23.0% (11) |
Severe vision reduction§ | 18.9% (12) | 19.5% (13) | 18.2% (14) | 16.2% (15) | 22.7% (12) |
Cancers§ | 18.3% (13) | 15.5% (14) | 22.4% (12) | 17.6% (12) | 19.3% (13) |
Depression§ | 17.8% (14) | 22.6% (11) | 10.6% (22) | 18.6% (11) | 16.7% (17) |
Purine/pyrimidine metabolism disorders/Gout | 17.3% (15) | 12.9% (18) | 23.7% (10) | 16.3% (14) | 18.7% (14) |
Atherosclerosis/PAOD§ | 16.7% (16) | 12.0% (19) | 23.4% (11) | 15.2% (16) | 18.6% (15) |
Intestinal diverticulosis§ | 14.5% (17) | 15.5% (14) | 13.0% (20) | 14.5% (18) | 14.5% (18) |
Neuropathies§ | 14.7% (18) | 13.0% (17) | 17.3% (15) | 15.1% (17) | 14.2% (20) |
Cardiac insufficiency§ | 13.1% (19) | 11.8% (20) | 15.0% (19) | 9.6% (22) | 17.7% (16) |
Chronic gastritis/GERD# | 12.9% (20) | 13.6% (16) | 11.9% (21) | 14.0% (19) | 11.5% (23) |
Cerebral ischemia/Chronic stroke§ | 11.8% (21) | 9.5% (22) | 15.1% (18) | 9.9% (21) | 14.4% (19) |
Prostatic hyperplasia | 11.4% (22) | - | 27.9% (8) | 10.5% (20) | 12.6% (22) |
Renal insufficiency§ | 10.7% (23) | 7.1% (27) | 15.8% (16) | 8.2% (24) | 14.0% (21) |
Cardiac valve disorders§ | 9.4% (24) | 8.8% (23) | 10.3% (23) | 8.0% (26) | 11.3% (24) |
Chronic cholecystitis/Gallstones | 7.9% (25) | 8.3% (25) | 7.2% (26) | 6.7% (28) | 9.5% (25) |
Dizziness§ | 7.7% (26) | 8.7% (24) | 6.3% (29) | 6.7% (28) | 9.1% (27) |
Liver diseases§ | 7.7% (27) | 6.8% (28) | 9.0% (25) | 8.7% (23) | 6.4% (29) |
Haemorrhoids | 7.5% (28) | 5.6% (30) | 10.3% (23) | 8.1%(25) | 6.7% (28) |
Urinary incontinence§ | 7.2% (29) | 9.9% (21) | 3.3% (36) | 5.6% (30) | 9.3% (26) |
Somatoform disorders§ | 6.1% (30) | 7.7% (26) | 3.7% (34) | 7.0% (27) | 4.9% (32) |
Insomnia# | 5.6% (31) | 5.1% (33) | 6.2% (30) | 5.4% (32) | 5.7% (31) |
Severe hearing loss§ | 5.2% (32) | 4.2% (36) | 6.8% (28) | 4.7% (34) | 6.0% (30) |
Allergies# | 4.9% (33) | 6.0% (29) | 3.4% (35) | 5.8% (29) | 3.8% (36) |
Obesity# | 4.8% (34) | 4.8% (35) | 4.9% (33) | 5.5% (31) | 3.9% (35) |
Anemias§ | 4.3% (35) | 3.1% (38) | 5.9% (31) | 3.9% (38) | 4.8% (33) |
Rheumatoid arthritis/Chronic polyarthritis§ | 4.2% (36) | 5.6% (31) | 2.2% (39) | 3.9% (37) | 4.6% (34) |
Anxiety§ | 4.1% (37) | 5.3% (32) | 2.2% (39) | 4.7% (34) | 3.2% (37) |
Psoriasis§ | 3.6% (38) | 2.7% (39) | 5.0% (32) | 4.3% (36) | 2.8% (39) |
Migraine/chronic headache§ | 3.5% (39) | 4.9% (34) | 1.5% (41) | 5.0% (33) | 1.5% (41) |
Noninflammatory gynaecological problems | 2.0% (40) | 3.4% (37) | - | 2.5% (39) | 1.4% (42) |
Parkinson's disease§ | 1.9% (41) | 1.4% (40) | 2.8% (37) | 1.3% (41) | 2.9% (38) |
Urinary tract calculi | 1.8% (42) | 1.3% (41) | 2.6% (38) | 1.6% (40) | 2.1% (40) |
Hypotension# | 0.5% (43) | 0.5% (42) | 0.4% (43) | 0.4% (42) | 0.6% (43) |
Sexual dysfunction# | 0.2% (44) | - | 0.5% (42) | 0.3% (43) | - |
Tobacco abuse# | 0.1% (45) | 0 (43) | 0.2% (44) | 0.1% (44) | - |
Dementias* | - | - | - | - | - |